| Year |
Citation |
Score |
| 2022 |
Kohut SJ, Cao L, Mintzopolous D, Jiang S, Nikas SP, Makriyannis A, Zou CS, Jensen JE, Frederick BB, Bergman J, Kangas BD. Effects of cannabinoid exposure on short-term memory and medial orbitofrontal cortex function and chemistry in adolescent female rhesus macaques. Frontiers in Neuroscience. 16: 998351. PMID 36248648 DOI: 10.3389/fnins.2022.998351 |
0.779 |
|
| 2022 |
Linton SR, Murphy M, Schroder HS, Breiger M, Iturra-Mena AM, Kangas BD, Bergman J, Carlezon WA, Risbrough VB, Barnes SA, Der-Avakian A, Pizzagalli DA. Effects of modafinil on electroencephalographic microstates in healthy adults. Psychopharmacology. PMID 35471613 DOI: 10.1007/s00213-022-06149-x |
0.643 |
|
| 2022 |
Withey SL, Cao L, de Moura FB, Cayetano KR, Rohan ML, Bergman J, Kohut SJ. Fentanyl-induced changes in brain activity in awake nonhuman primates at 9.4 Tesla. Brain Imaging and Behavior. PMID 35226333 DOI: 10.1007/s11682-022-00639-4 |
0.788 |
|
| 2022 |
Johnson CR, Kangas BD, Jutkiewicz EM, Bergman J, Coop A. Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders. Biomedicines. 10. PMID 35203607 DOI: 10.3390/biomedicines10020398 |
0.642 |
|
| 2022 |
Schroder HS, Iturra-Mena AM, Breiger M, Linton SR, Robble MA, Kangas B, Bergman J, Nickels S, Vitaliano G, Der-Avakian A, Barnes SA, Carlezon WA, Pizzagalli DA. Error-related Alpha Suppression: Scalp Topography and (Lack of) Modulation by Modafinil. Journal of Cognitive Neuroscience. 1-12. PMID 35195725 DOI: 10.1162/jocn_a_01836 |
0.649 |
|
| 2021 |
Kangas BD, Iturra-Mena AM, Robble MA, Luc OT, Potter D, Nickels S, Bergman J, Carlezon WA, Pizzagalli DA. Concurrent electrophysiological recording and cognitive testing in a rodent touchscreen environment. Scientific Reports. 11: 11665. PMID 34083596 DOI: 10.1038/s41598-021-91091-9 |
0.641 |
|
| 2021 |
Wakeford AGP, Sherwood AM, Prisinzano TE, Bergman J, Kohut SJ, Paronis CA. Discriminative-stimulus effects of synthetic cathinones in squirrel monkeys. The International Journal of Neuropsychopharmacology. PMID 33909067 DOI: 10.1093/ijnp/pyab017 |
0.671 |
|
| 2021 |
Robble MA, Schroder HS, Kangas BD, Nickels S, Breiger M, Iturra-Mena AM, Perlo S, Cardenas E, Der-Avakian A, Barnes SA, Leutgeb S, Risbrough VB, Vitaliano G, Bergman J, Carlezon WA, et al. Concordant neurophysiological signatures of cognitive control in humans and rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 33746206 DOI: 10.1038/s41386-021-00998-4 |
0.653 |
|
| 2021 |
Johnson CR, Kangas BD, Jutkiewicz EM, Winger G, Bergman J, Coop A. Novel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on Cognition. The Journal of Pharmacology and Experimental Therapeutics. PMID 33712507 DOI: 10.1124/jpet.120.000337 |
0.689 |
|
| 2021 |
Withey SL, Kangas BD, Charles S, Gumbert AB, Eisold JE, George SR, Bergman J, Madras BK. Effects of daily Δ-Tetrahydrocannabinol (THC) alone or combined with cannabidiol (CBD) on cognition-based behavior and activity in adolescent nonhuman primates. Drug and Alcohol Dependence. 221: 108629. PMID 33640678 DOI: 10.1016/j.drugalcdep.2021.108629 |
0.781 |
|
| 2021 |
de Moura FB, Sherwood A, Prisinzano TE, Paronis CA, Bergman J, Kohut SJ. Reinforcing effects of synthetic cathinones in rhesus monkeys: Dose-response and behavioral economic analyses. Pharmacology, Biochemistry, and Behavior. 173112. PMID 33444603 DOI: 10.1016/j.pbb.2021.173112 |
0.808 |
|
| 2021 |
de Moura FB, Bergman J. Enhancement of opioid antinociception by nicotinic ligands. The Journal of Pharmacology and Experimental Therapeutics. PMID 33441370 DOI: 10.1124/jpet.120.000423 |
0.798 |
|
| 2020 |
Wooldridge LM, Bergman J, Pizzagalli DA, Kangas BD. Translational Assessments of Reward Responsiveness in the Marmoset. The International Journal of Neuropsychopharmacology. PMID 33280005 DOI: 10.1093/ijnp/pyaa090 |
0.652 |
|
| 2020 |
Kohut SJ, Mintzopoulos D, Kangas BD, Shields H, Brown K, Gillis TE, Rohan ML, Bergman J, Kaufman MJ. Effects of long-term cocaine self-administration on brain resting-state functional connectivity in nonhuman primates. Translational Psychiatry. 10: 420. PMID 33268770 DOI: 10.1038/s41398-020-01101-z |
0.797 |
|
| 2020 |
Kangas BD, Wooldridge LM, Luc OT, Bergman J, Pizzagalli DA. Empirical validation of a touchscreen probabilistic reward task in rats. Translational Psychiatry. 10: 285. PMID 32792526 DOI: 10.1038/S41398-020-00969-1 |
0.69 |
|
| 2020 |
Withey SL, Bergman J, Huestis MA, George SR, Madras BK. THC and CBD blood and brain concentrations following daily administration to adolescent primates. Drug and Alcohol Dependence. 213: 108129. PMID 32593153 DOI: 10.1016/J.Drugalcdep.2020.108129 |
0.757 |
|
| 2020 |
Wooldridge LM, Ji L, Liu Y, Nikas SP, Makriyannis A, Bergman J, Kangas BD. Antiemetic Effects of Cannabinoid Agonists in Nonhuman Primates. The Journal of Pharmacology and Experimental Therapeutics. PMID 32561684 DOI: 10.1124/Jpet.120.265710 |
0.715 |
|
| 2020 |
Wang M, Irvin TC, Herdman CA, Hanna RD, Hassan SA, Lee YS, Kaska S, Crowley RS, Prisinzano TE, Withey SL, Paronis CA, Bergman J, Inan S, Geller EB, Adler MW, et al. The Intriguing Effects of Substituents in the -Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of "Tail Wags Dog" Experiments. Molecules (Basel, Switzerland). 25. PMID 32517185 DOI: 10.3390/Molecules25112640 |
0.719 |
|
| 2020 |
Withey SL, Eisold JE, Chelini G, Kangas BD, Bergman J, Madras BK. Behavioral and Molecular Effects of THC and CBD in Adolescent Nonhuman Primates The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.09462 |
0.771 |
|
| 2020 |
Borgatti D, Bergman J, Kohut S. Effects of Lorcaserin on Opioid‐Induced Observable Behavior in Rhesus Monkeys The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.07330 |
0.697 |
|
| 2020 |
Desai RI, Honrao C, Dawes M, Ma X, Solakidou E, Makriyannis A, Bergman J. Behavioral Effects of
d‐
Methamphetamine and s
in vivo
microdialysis in rats The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.03555 |
0.673 |
|
| 2020 |
Moura FBd, Bergman J. Receptor Mechanisms in Nicotinic Enhancement of Opioid Antinociception The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.02610 |
0.338 |
|
| 2019 |
Hasbi A, Madras BK, Bergman J, Kohut S, Lin Z, Withey SL, George SR. Δ-Tetrahydrocannabinol Increases Dopamine D1-D2 Receptor Heteromer and Elicits Phenotypic Reprogramming in Adult Primate Striatal Neurons. Iscience. 23: 100794. PMID 31972514 DOI: 10.1016/J.Isci.2019.100794 |
0.768 |
|
| 2019 |
Withey SL, Doyle RJ, Porter EN, Bergman J, Kangas BD. Discrimination learning in oxycodone-treated nonhuman primates. Drug and Alcohol Dependence. 207: 107778. PMID 31816487 DOI: 10.1016/J.Drugalcdep.2019.107778 |
0.789 |
|
| 2019 |
Kangas BD, Zakarian AS, Vemuri K, Alapafuja SO, Jiang S, Nikas SP, Makriyannis A, Bergman J. Cannabinoid Antagonist Drug Discrimination in Nonhuman Primates. The Journal of Pharmacology and Experimental Therapeutics. PMID 31641018 DOI: 10.1124/Jpet.119.261818 |
0.723 |
|
| 2019 |
de Moura FB, Withey SL, Bergman J. Enhancement of opioid antinociception by nicotine. The Journal of Pharmacology and Experimental Therapeutics. PMID 31527281 DOI: 10.1124/Jpet.119.261438 |
0.752 |
|
| 2019 |
Withey SL, Spealman RD, Bergman J, Paronis CA. Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment. The Journal of Pharmacology and Experimental Therapeutics. PMID 31413139 DOI: 10.1124/Jpet.119.259010 |
0.745 |
|
| 2019 |
de Moura FB, Kohut SJ, Bergman J. Medications development for food-based and drug use disorders. Advances in Pharmacology (San Diego, Calif.). 86: 197-236. PMID 31378252 DOI: 10.1016/Bs.Apha.2019.04.005 |
0.787 |
|
| 2019 |
Bardo MT, Denehy ED, Hammerslag LR, Dwoskin LP, Blough BE, Landavazo A, Bergman J, Kohut SJ. Effects of methamphetamine isomers on d-methamphetamine self-administration and food-maintained responding in male rats. Psychopharmacology. PMID 31346628 DOI: 10.1007/S00213-019-05327-8 |
0.713 |
|
| 2019 |
Kangas BD, Doyle RJ, Kohut SJ, Bergman J, Kaufman MJ. Effects of chronic cocaine self-administration and N-acetylcysteine on learning, cognitive flexibility, and reinstatement in nonhuman primates. Psychopharmacology. PMID 30877326 DOI: 10.1007/S00213-019-05211-5 |
0.801 |
|
| 2018 |
Kohut SJ, Bergman J. Lorcaserin decreases the reinforcing effects of heroin, but not food, in rhesus monkeys. European Journal of Pharmacology. PMID 30268662 DOI: 10.1016/J.Ejphar.2018.09.025 |
0.733 |
|
| 2018 |
de Moura FB, Kohut SJ, Bergman J. Limited modulation of the abuse-related behavioral effects of d-methamphetamine by disulfiram. Experimental and Clinical Psychopharmacology. PMID 29963872 DOI: 10.1037/Pha0000222 |
0.81 |
|
| 2018 |
Withey SL, Doyle MR, Bergman J, Desai RI. Involvement of Nicotinic Receptor Subtypes in Behavioral Effects of Nicotinic Drugs in Squirrel Monkeys. The Journal of Pharmacology and Experimental Therapeutics. PMID 29784663 DOI: 10.1124/Jpet.118.248070 |
0.795 |
|
| 2018 |
Withey SL, Paronis CA, Bergman J. Concurrent Assessment of the Antinociceptive and Behaviorally Disruptive Effects of Opioids in Squirrel Monkeys. The Journal of Pain : Official Journal of the American Pain Society. PMID 29477761 DOI: 10.1016/J.Jpain.2018.02.003 |
0.752 |
|
| 2018 |
Fischer KD, Houston ACW, Desai RI, Doyle MR, Bergman J, Mian M, Mannix R, Sulzer DL, Choi SJ, Mosharov EV, Hodgson NW, Bechtholt A, Miczek KA, Rosenberg PA. Behavioral phenotyping and dopamine dynamics in mice with conditional deletion of the glutamate transporter GLT-1 in neurons: resistance to the acute locomotor effects of amphetamine. Psychopharmacology. PMID 29468294 DOI: 10.1007/S00213-018-4848-1 |
0.707 |
|
| 2018 |
Paronis CA, Chopda GR, Vemuri K, Zakarian AS, Makriyannis A, Bergman J. Long-lasting in vivo effects of the cannabinoid CB1 antagonist AM6538. The Journal of Pharmacology and Experimental Therapeutics. PMID 29311110 DOI: 10.1124/Jpet.117.245647 |
0.388 |
|
| 2017 |
Puhl MD, Desai RI, Takagi S, Presti KT, Doyle MR, Donahue RJ, Landino SM, Bergman J, Carlezon WA, Coyle JT. N-Methyl-d-aspartate receptor co-agonist availability affects behavioral and neurochemical responses to cocaine: insights into comorbid schizophrenia and substance abuse. Addiction Biology. PMID 29168271 DOI: 10.1111/Adb.12577 |
0.713 |
|
| 2017 |
Kangas BD, Bergman J. Touchscreen technology in the study of cognition-related behavior. Behavioural Pharmacology. PMID 29064843 DOI: 10.1097/Fbp.0000000000000356 |
0.697 |
|
| 2017 |
Jacobs DS, Barkin CE, Kohut MR, Bergman J, Kohut SJ. Effects of lorcaserin (Belviq(®)) on nicotine- and food-maintained responding in non-human primates. Drug and Alcohol Dependence. 181: 94-101. PMID 29040827 DOI: 10.1016/J.Drugalcdep.2017.09.008 |
0.712 |
|
| 2017 |
Leonard MZ, Alapafuja SO, Ji L, Shukla VG, Liu Y, Nikas SP, Makriyannis A, Bergman J, Kangas BD. Cannabinoid CB1 Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors. The Journal of Pharmacology and Experimental Therapeutics. PMID 28947487 DOI: 10.1124/Jpet.117.244392 |
0.702 |
|
| 2017 |
Kohut SJ, Jacobs DS, Rothman RB, Partilla JS, Bergman J, Blough BE. Cocaine-like discriminative stimulus effects of "norepinephrine-preferring" monoamine releasers: time course and interaction studies in rhesus monkeys. Psychopharmacology. PMID 28889212 DOI: 10.1007/S00213-017-4731-5 |
0.702 |
|
| 2017 |
Kohut S, Barkin C, Bergman J. Effects of chronic nicotine treatment and discontinuation on nicotine self-administration Drug and Alcohol Dependence. 171: e107-e108. DOI: 10.1016/J.Drugalcdep.2016.08.301 |
0.684 |
|
| 2016 |
Jacobs DS, Kohut SJ, Jiang S, Nikas SP, Makriyannis A, Bergman J. Acute and chronic effects of cannabidiol on Δ⁹-tetrahydrocannabinol (Δ⁹-THC)-induced disruption in stop signal task performance. Experimental and Clinical Psychopharmacology. 24: 320-330. PMID 27690502 DOI: 10.1037/Pha0000081 |
0.709 |
|
| 2016 |
Kohut SJ, Bergman J. Reinforcing effectiveness of nicotine in nonhuman primates: effects of nicotine dose and history of nicotine self-administration. Psychopharmacology. PMID 27076210 DOI: 10.1007/S00213-016-4293-Y |
0.693 |
|
| 2016 |
Desai RI, Sullivan KA, Kohut SJ, Bergman J. Influence of experimental history on nicotine self-administration in squirrel monkeys. Psychopharmacology. PMID 27040402 DOI: 10.1007/S00213-016-4274-1 |
0.781 |
|
| 2016 |
Desai RI, Doyle MR, Withey SL, Bergman J. Nicotinic effects of tobacco smoke constituents in nonhuman primates. Psychopharmacology. PMID 26892379 DOI: 10.1007/S00213-016-4238-5 |
0.771 |
|
| 2016 |
Schindler CW, Redhi GH, Vemuri K, Makriyannis A, Le Foll B, Bergman J, Goldberg SR, Justinova Z. Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26888056 DOI: 10.1038/Npp.2016.27 |
0.455 |
|
| 2016 |
Kangas BD, Bergman J, Coyle JT. Touchscreen assays of learning, response inhibition, and motivation in the marmoset (Callithrix jacchus). Animal Cognition. PMID 26846231 DOI: 10.1007/S10071-016-0959-4 |
0.675 |
|
| 2016 |
Kangas BD, Leonard MZ, Shukla VG, Alapafuja SO, Nikas SP, Makriyannis A, Bergman J. Comparisons of Δ9-tetrahydrocannabinol and Anandamide on a Battery of Cognition-related Behavior in Nonhuman Primates. The Journal of Pharmacology and Experimental Therapeutics. PMID 26826191 DOI: 10.1124/Jpet.115.228189 |
0.716 |
|
| 2016 |
Desai RI, Bergman J. Nicotine-Targeting Nano-Vaccines for Smoking Cessation. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 41: 377-8. PMID 26657956 DOI: 10.1038/Npp.2015.234 |
0.639 |
|
| 2015 |
Kohut SJ, Bergman J, Blough BE. Effects of L-methamphetamine treatment on cocaine- and food-maintained behavior in rhesus monkeys. Psychopharmacology. PMID 26713332 DOI: 10.1007/S00213-015-4186-5 |
0.724 |
|
| 2015 |
Kangas BD, Bergman J. Effects of self-administered methamphetamine on discrimination learning and reversal in nonhuman primates. Psychopharmacology. PMID 26490034 DOI: 10.1007/S00213-015-4107-7 |
0.698 |
|
| 2015 |
Bergman J, Rheingold CG. Dopamine D₄ Receptor Antagonists for the Treatment of Cocaine Use Disorders. Cns & Neurological Disorders Drug Targets. 14: 707-15. PMID 26022267 DOI: 10.2174/1871527314666150529132723 |
0.417 |
|
| 2015 |
Desai RI, Bergman J. Effects of the Nanoparticle-Based Vaccine, SEL-068, on Nicotine Discrimination in Squirrel Monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 2207-16. PMID 25742871 DOI: 10.1038/Npp.2015.64 |
0.689 |
|
| 2015 |
Willner P, Bergman J, Vanderschuren L, Ellenbroek B. The behavioural pharmacology of the basal ganglia: in memory of Lex Cools. Behavioural Pharmacology. 26: 1-2. PMID 25539481 DOI: 10.1097/Fbp.0000000000000125 |
0.301 |
|
| 2015 |
Spealman RD, Bergman J. Modulation of reinstated polydrug (cocaine/heroin) seeking by noradrenergic α 2 agonists Drug and Alcohol Dependence. 156: e209. DOI: 10.1016/J.Drugalcdep.2015.07.563 |
0.384 |
|
| 2015 |
Kohut S, Blough B, Bergman J. Effects of l -methamphetamine on the discriminative stimulus and reinforcing effects of cocaine Drug and Alcohol Dependence. 156: e116. DOI: 10.1016/J.Drugalcdep.2015.07.321 |
0.68 |
|
| 2015 |
Spealman RD, Bergman J. Modulation Of Behavioral Effects Of Polydrug (Cocaine/Heroin) Mixtures By Alpha-2 Agonists Drug and Alcohol Dependence. 146: e105. DOI: 10.1016/J.Drugalcdep.2014.09.653 |
0.367 |
|
| 2014 |
Kangas BD, Bergman J. Operant nociception in nonhuman primates. Pain. 155: 1821-8. PMID 24968803 DOI: 10.1016/J.Pain.2014.06.010 |
0.723 |
|
| 2014 |
Desai RI, Bergman J. Methamphetamine-like discriminative-stimulus effects of nicotinic agonists. The Journal of Pharmacology and Experimental Therapeutics. 348: 478-88. PMID 24389640 DOI: 10.1124/Jpet.113.211235 |
0.712 |
|
| 2014 |
Kangas BD, Bergman J. Repeated acquisition and discrimination reversal in the squirrel monkey (Saimiri sciureus). Animal Cognition. 17: 221-8. PMID 23794073 DOI: 10.1007/S10071-013-0654-7 |
0.672 |
|
| 2013 |
Justinova Z, Mascia P, Wu HQ, Secci ME, Redhi GH, Panlilio LV, Scherma M, Barnes C, Parashos A, Zara T, Fratta W, Solinas M, Pistis M, Bergman J, Kangas BD, et al. Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid. Nature Neuroscience. 16: 1652-61. PMID 24121737 DOI: 10.1038/Nn.3540 |
0.717 |
|
| 2013 |
Kangas BD, Delatte MS, Vemuri VK, Thakur GA, Nikas SP, Subramanian KV, Shukla VG, Makriyannis A, Bergman J. Cannabinoid discrimination and antagonism by CB(1) neutral and inverse agonist antagonists. The Journal of Pharmacology and Experimental Therapeutics. 344: 561-7. PMID 23287700 DOI: 10.1124/Jpet.112.201962 |
0.714 |
|
| 2013 |
Desai RI, Thakur GA, Vemuri VK, Bajaj S, Makriyannis A, Bergman J. Analysis of tolerance and behavioral/physical dependence during chronic CB1 agonist treatment: effects of CB1 agonists, antagonists, and noncannabinoid drugs. The Journal of Pharmacology and Experimental Therapeutics. 344: 319-28. PMID 23197773 DOI: 10.1124/Jpet.112.198374 |
0.718 |
|
| 2013 |
Mello NK, Fivel PA, Kohut SJ, Bergman J. Effects of chronic buspirone treatment on cocaine self-administration. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 455-67. PMID 23072835 DOI: 10.1038/Npp.2012.202 |
0.723 |
|
| 2013 |
Paronis CA, Thakur GA, Bajaj S, Nikas SP, Vemuri VK, Makriyannis A, Bergman J. Diuretic effects of cannabinoids. The Journal of Pharmacology and Experimental Therapeutics. 344: 8-14. PMID 23019138 DOI: 10.1124/Jpet.112.199331 |
0.396 |
|
| 2013 |
Bergman J, Roof RA, Furman CA, Conroy JL, Mello NK, Sibley DR, Skolnick P. Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 445-58. PMID 22827916 DOI: 10.1017/S1461145712000661 |
0.413 |
|
| 2013 |
Schindler CW, Justinova Z, Lafleur D, Woods D, Roschke V, Hallak H, Sklair-Tavron L, Redhi GH, Yasar S, Bergman J, Goldberg SR. Modification of pharmacokinetic and abuse-related effects of cocaine by human-derived cocaine hydrolase in monkeys. Addiction Biology. 18: 30-9. PMID 22264200 DOI: 10.1111/J.1369-1600.2011.00424.X |
0.384 |
|
| 2013 |
Kangas BD, Nikas SP, Shukla VG, Subramanian KV, Makriyannis A, Bergman J. H.6 - EFFECTS OF ANANDAMIDE AND OTHER CB1 LIGANDS ON LEARNING AND COGNITIVE FLEXIBILITY IN NONHUMAN PRIMATES Behavioural Pharmacology. 24: e62. DOI: 10.1097/01.Fbp.0000434885.08189.06 |
0.657 |
|
| 2013 |
Desai RI, Bergman J. F.1 - MEDICATION STRATEGIES FOR TOBACCO ADDICTION Behavioural Pharmacology. 24: e49. DOI: 10.1097/01.Fbp.0000434847.40537.D7 |
0.64 |
|
| 2013 |
Barrett JE, Bergman J, Katz JL, Morse WH. Peter B Dews Neuropsychopharmacology. 38: 2733-2733. DOI: 10.1038/Npp.2013.276 |
0.353 |
|
| 2012 |
Kangas BD, Bergman J. A novel touch-sensitive apparatus for behavioral studies in unrestrained squirrel monkeys. Journal of Neuroscience Methods. 209: 331-6. PMID 22790109 DOI: 10.1016/J.Jneumeth.2012.06.028 |
0.703 |
|
| 2012 |
Newman AH, Blaylock BL, Nader MA, Bergman J, Sibley DR, Skolnick P. Medication discovery for addiction: translating the dopamine D3 receptor hypothesis. Biochemical Pharmacology. 84: 882-90. PMID 22781742 DOI: 10.1016/J.Bcp.2012.06.023 |
0.411 |
|
| 2011 |
Paronis CA, Bergman J. Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal. The Journal of Pharmacology and Experimental Therapeutics. 336: 488-95. PMID 21051498 DOI: 10.1124/Jpet.110.173823 |
0.399 |
|
| 2011 |
Bergman J, Woods JH. Charles Roberts Schuster Neuropsychopharmacology. 36: 2782-2782. DOI: 10.1038/Npp.2011.71 |
0.316 |
|
| 2010 |
Desai RI, Bergman J. Drug discrimination in methamphetamine-trained rats: effects of cholinergic nicotinic compounds. The Journal of Pharmacology and Experimental Therapeutics. 335: 807-16. PMID 20847037 DOI: 10.1124/Jpet.110.173773 |
0.715 |
|
| 2010 |
Desai RI, Paronis CA, Martin J, Desai R, Bergman J. Monoaminergic psychomotor stimulants: discriminative stimulus effects and dopamine efflux. The Journal of Pharmacology and Experimental Therapeutics. 333: 834-43. PMID 20190012 DOI: 10.1124/Jpet.110.165746 |
0.715 |
|
| 2008 |
Bergman J. Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify). Experimental and Clinical Psychopharmacology. 16: 475-83. PMID 19086768 DOI: 10.1037/A0014398 |
0.478 |
|
| 2008 |
Bergman J, Delatte MS, Paronis CA, Vemuri K, Thakur GA, Makriyannis A. Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties. Physiology & Behavior. 93: 666-70. PMID 18076956 DOI: 10.1016/J.Physbeh.2007.11.007 |
0.416 |
|
| 2007 |
Desai RI, Neumeyer JL, Bergman J, Paronis CA. Pharmacological characterization of the effects of dopamine D(1) agonists on eye blinking in rats. Behavioural Pharmacology. 18: 745-54. PMID 17989512 DOI: 10.1097/Fbp.0B013E3282F14Ee6 |
0.697 |
|
| 2007 |
Schindler CW, Graczyk Z, Gilman JP, Negus SS, Bergman J, Mello NK, Goldberg SR. Effects of kappa opioid agonists alone and in combination with cocaine on heart rate and blood pressure in conscious squirrel monkeys. European Journal of Pharmacology. 576: 107-13. PMID 17707792 DOI: 10.1016/J.Ejphar.2007.07.053 |
0.395 |
|
| 2007 |
Desai RI, Neumeyer JL, Paronis CA, Nguyen P, Bergman J. Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeys. European Journal of Pharmacology. 558: 98-106. PMID 17207791 DOI: 10.1016/J.Ejphar.2006.11.042 |
0.719 |
|
| 2007 |
Delatte MS, Brimson M, Rohan M, Kaufman M, Bergman J. MRI‐compatible procedures for behavioral pharmacology in squirrel monkeys The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A411 |
0.315 |
|
| 2007 |
Paronis CA, Thakur GA, Vemuri K, Makriyannis A, Bergman J. Partial Agonist and Antagonist Effects of Δ9‐tetrahydrocannabinol (Δ9THC) in rats The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A409-A |
0.305 |
|
| 2007 |
Desai RI, Neumeyer JL, Paronis CA, Nguyen P, Bergman J. Erratum to: Behavioral effects of the R-(+)- and S-(−)-enantiomers of the dopamine D1-like partial receptor agonist SKF 83959 in monkeys [European Journal of Pharmacology 558 (2007) 98106] European Journal of Pharmacology. 575: 187. DOI: 10.1016/J.Ejphar.2007.08.013 |
0.7 |
|
| 2006 |
Bergman J, Paronis CA. Measuring the reinforcing strength of abused drugs. Molecular Interventions. 6: 273-83. PMID 17035668 DOI: 10.1124/Mi.6.5.9 |
0.314 |
|
| 2005 |
Yasar S, Gaal J, Justinova Z, Bergman J. Discriminative stimulus and reinforcing effects of p-fluoro-L-deprenyl in monkeys. Psychopharmacology. 182: 95-103. PMID 15990999 DOI: 10.1007/S00213-005-0063-Y |
0.362 |
|
| 2005 |
Gasior M, Bergman J, Kallman MJ, Paronis CA. Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 758-64. PMID 15526000 DOI: 10.1038/Sj.Npp.1300593 |
0.445 |
|
| 2004 |
Jutkiewicz EM, Bergman J. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions. The Journal of Pharmacology and Experimental Therapeutics. 311: 1008-15. PMID 15292458 DOI: 10.1124/Jpet.104.071092 |
0.334 |
|
| 2004 |
Czoty PW, Ramanathan CR, Mutschler NH, Makriyannis A, Bergman J. Drug discrimination in methamphetamine-trained monkeys: effects of monoamine transporter inhibitors. The Journal of Pharmacology and Experimental Therapeutics. 311: 720-7. PMID 15240827 DOI: 10.1124/Jpet.104.071035 |
0.661 |
|
| 2004 |
Czoty PW, Makriyannis A, Bergman J. Methamphetamine discrimination and in vivo microdialysis in squirrel monkeys. Psychopharmacology. 175: 170-8. PMID 15064912 DOI: 10.1007/S00213-004-1798-6 |
0.685 |
|
| 2004 |
Gasior M, Paronis CA, Bergman J. Modification by dopaminergic drugs of choice behavior under concurrent schedules of intravenous saline and food delivery in monkeys. The Journal of Pharmacology and Experimental Therapeutics. 308: 249-59. PMID 14563783 DOI: 10.1124/Jpet.103.052795 |
0.438 |
|
| 2003 |
Neumeyer JL, Kula NS, Bergman J, Baldessarini RJ. Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines. European Journal of Pharmacology. 474: 137-40. PMID 12921854 DOI: 10.1016/S0014-2999(03)02008-9 |
0.325 |
|
| 2003 |
Yasar S, Bergman J, Munzar P, Redhi G, Tober C, Knebel N, Zschiesche M, Paronis C. Evaluation of the novel antiepileptic drug, AWD 131-138, for benzodiazepine-like discriminative stimulus and reinforcing effects in squirrel monkeys. European Journal of Pharmacology. 465: 257-65. PMID 12681437 DOI: 10.1016/S0014-2999(03)01533-4 |
0.398 |
|
| 2002 |
Paronis CA, Gasior M, Bergman J. Effects of cocaine under concurrent fixed ratio schedules of food and IV drug availability: a novel choice procedure in monkeys. Psychopharmacology. 163: 283-91. PMID 12373429 DOI: 10.1007/S00213-002-1180-5 |
0.391 |
|
| 2002 |
Bergman J, Katz JL, Miczek KA. The experimental imperative. Psychopharmacology. 163: 249-50. PMID 12373426 DOI: 10.1007/S00213-002-1226-8 |
0.436 |
|
| 2002 |
Mutschler NH, Bergman J. Effects of chronic administration of the D1 receptor partial agonist SKF 77434 on cocaine self-administration in rhesus monkeys. Psychopharmacology. 160: 362-70. PMID 11919663 DOI: 10.1007/S00213-001-0976-Z |
0.441 |
|
| 2002 |
Bergman J, Yasar S, Winger G. Psychomotor stimulant effects of β-phenylethylamine in monkeys treated with MAO-B inhibitors Psychopharmacology. 159: 21-30. PMID 11797065 DOI: 10.1007/S002130100890 |
0.346 |
|
| 2002 |
Schindler CW, Gilman JP, Bergman J, Mello NK, Woosley RL, Goldberg SR. Interactions between cocaine and dopamine agonists on cardiovascular function in squirrel monkeys. The Journal of Pharmacology and Experimental Therapeutics. 300: 180-7. PMID 11752114 DOI: 10.1124/Jpet.300.1.180 |
0.384 |
|
| 2001 |
Paronis CA, Cox ED, Cook JM, Bergman J. Different types of GABA(A) receptors may mediate the anticonflict and response rate-decreasing effects of zaleplon, zolpidem, and midazolam in squirrel monkeys. Psychopharmacology. 156: 461-8. PMID 11498724 DOI: 10.1007/S002130100754 |
0.332 |
|
| 2000 |
Bergman J, France CP, Holtzman SG, Katz JL, Koek W, Stephens DN. Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABAA-ergic ligands. Psychopharmacology. 153: 67-84. PMID 11255930 DOI: 10.1007/S002130000567 |
0.407 |
|
| 1999 |
Caine SB, Negus SS, Mello NK, Bergman J. Effects of dopamine D(1-like) and D(2-like) agonists in rats that self-administer cocaine. The Journal of Pharmacology and Experimental Therapeutics. 291: 353-60. PMID 10490924 |
0.305 |
|
| 1998 |
Tidey JW, Bergman J. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs. The Journal of Pharmacology and Experimental Therapeutics. 285: 1163-74. PMID 9618419 |
0.595 |
|
| 1998 |
Bergman J. DISCRIMINATIVE-STIMULUS EFFECTS OF DOPAMINERGIC DRUGS Behavioural Pharmacology. 9: S105. DOI: 10.1097/00008877-199808000-00241 |
0.321 |
|
| 1998 |
Paronis CA, Bergman J. AGONIST AND ANTAGONIST EFFECTS OF GABAA MODULATORS Behavioural Pharmacology. 9: S70. DOI: 10.1097/00008877-199808000-00159 |
0.336 |
|
| 1998 |
Bergman J, Mutschler N, Jutkiewicz E. EFFICACY-DEPENDENT DIFFERENCES IN BEHAVIORAL EFFECTS OF DOPAMINE D, AGONISTS IN MONKEYS Behavioural Pharmacology. 9: S15. DOI: 10.1097/00008877-199808000-00014 |
0.393 |
|
| 1997 |
Spealman RD, Bergman J, Rosenzweig-Lipson S. Differential modulation of behavioral effects of cocaine by low- and high-efficacy D1 agonists. Psychopharmacology. 133: 283-92. PMID 9361335 DOI: 10.1007/S002130050403 |
0.419 |
|
| 1997 |
Carey GJ, Bergman J. Discriminative-stimulus effects of clozapine in squirrel monkeys: Comparison with conventional and novel antipsychotic drugs Psychopharmacology. 132: 261-269. PMID 9292626 DOI: 10.1007/S002130050344 |
0.382 |
|
| 1996 |
Gatch MB, Liguori A, Negus SS, Mello NK, Bergman J, Liguori T. Naloxonazine antagonism of levorphanol-induced antinociception and respiratory depression in rhesus monkeys. European Journal of Pharmacology. 298: 31-6. PMID 8867916 DOI: 10.1016/0014-2999(95)00769-5 |
0.37 |
|
| 1996 |
Bergman J, Spealman RD, Madras BK, Rosenzweig-Lipson S. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys. The Journal of Pharmacology and Experimental Therapeutics. 276: 942-50. PMID 8786574 |
0.582 |
|
| 1996 |
Grech DM, Spealman RD, Bergman J. Self-administration of D1 receptor agonists by squirrel monkeys. Psychopharmacology. 125: 97-104. PMID 8783382 DOI: 10.1007/Bf02249407 |
0.391 |
|
| 1996 |
Bergman J, Miczek KA. The ameliorating addict: An illusion reviewed Behavioral and Brain Sciences. 19: 575-576. DOI: 10.1017/S0140525X00043016 |
0.556 |
|
| 1996 |
Gatch MB, Liguori A, Negus S, Mello NK, Bergman J. Corrigendum to ‘Naloxonazine antagonism of levorphanol-induced antinociception and respiratory depression in rhesus monkeys’ [Eur. J. Pharmacol. 298 (1996) 31–36] European Journal of Pharmacology. 312: 389. DOI: 10.1016/0014-2999(96)00413-X |
0.367 |
|
| 1994 |
Yasar S, Bergman J. Amphetamine-like effect of l-deprenyl (selegiline) in drug discrimination studies Clinical Pharmacology and Therapeutics. 56: 768-773. PMID 7995019 DOI: 10.1038/Clpt.1994.207 |
0.36 |
|
| 1994 |
Rosenzweig-Lipson S, Bergman J. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys European Journal of Pharmacology. 260: 237-241. PMID 7988649 DOI: 10.1016/0014-2999(94)90343-3 |
0.368 |
|
| 1994 |
Rosenzweig-Lipson S, Hesterberg P, Bergman J. Observational studies of dopamine D1 and D2 agonists in squirrel monkeys Psychopharmacology. 116: 9-18. PMID 7862937 DOI: 10.1007/Bf02244865 |
0.367 |
|
| 1993 |
Liguori A, Bergman J. Opioid-antagonist effects of naltrexone and naltrindole Pharmacology Biochemistry and Behavior. 46: 503. DOI: 10.1016/0091-3057(93)90414-O |
0.322 |
|
| 1992 |
Rosenzweig-Lipson S, Bergman J, Spealman RD, Madras BK. Stereoselective behavioral effects of Lu 19-005 in monkeys: relation to binding at cocaine recognition sites. Psychopharmacology. 107: 186-94. PMID 1377395 DOI: 10.1007/Bf02245136 |
0.624 |
|
| 1992 |
Spealman RD, Bergman J, Madras BK, Kamien JB, Melia KF. Role of D1 and D2 dopamine receptors in the behavioral effects of cocaine. Neurochemistry International. 20: 147S-152S. PMID 1365414 DOI: 10.1016/0197-0186(92)90228-J |
0.616 |
|
| 1991 |
Bergman J, Madras BK, Spealman RD. Behavioral effects of D1 and D2 dopamine receptor antagonists in squirrel monkeys. The Journal of Pharmacology and Experimental Therapeutics. 258: 910-7. PMID 1890625 |
0.539 |
|
| 1991 |
Spealman RD, Bergman J, Madras BK. Self-administration of the high-affinity cocaine analog 2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane. Pharmacology, Biochemistry, and Behavior. 39: 1011-3. PMID 1763097 DOI: 10.1016/0091-3057(91)90067-C |
0.611 |
|
| 1991 |
Spealman RD, Bergman J, Madras BK, Melia KF. Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes. The Journal of Pharmacology and Experimental Therapeutics. 258: 945-53. PMID 1679852 |
0.591 |
|
| 1990 |
Bergman J, Kamien JB, Spealman RD. Antagonism of cocaine self-administration by selective dopamine D(1) and D(2) antagonists. Behavioural Pharmacology. 1: 355-363. PMID 11175420 DOI: 10.1097/00008877-199000140-00009 |
0.314 |
|
| 1990 |
Bergman J. Psychomotor stimulant effects of the stereoisomers of chlorpheniramine Psychopharmacology. 101: 132-134. PMID 1967498 DOI: 10.1007/Bf02245804 |
0.381 |
|
| 1989 |
Spealman RD, Madras BK, Bergman J. Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior. The Journal of Pharmacology and Experimental Therapeutics. 251: 142-9. PMID 2795456 |
0.598 |
|
| 1989 |
Bergman J, Madras BK, Johnson SE, Spealman RD. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. The Journal of Pharmacology and Experimental Therapeutics. 251: 150-5. PMID 2529365 |
0.601 |
|
| 1986 |
Bergman J, Glowa JR. Suppression of behavior by food pellet-lithium chloride pairings in squirrel monkeys Pharmacology, Biochemistry and Behavior. 25: 973-978. PMID 3024186 DOI: 10.1016/0091-3057(86)90072-9 |
0.377 |
|
| 1985 |
Bergman J, Schuster CR. Behavioral effects of naloxone and nalorphine preceding and following morphine maintenance in the rhesus monkey. Psychopharmacology. 86: 324-7. PMID 3929303 DOI: 10.1007/Bf00432222 |
0.583 |
|
| 1985 |
Bergman J, Johanson CE. The reinforcing properties of diazepam under several conditions in the rhesus monkey. Psychopharmacology. 86: 108-13. PMID 3927346 DOI: 10.1007/Bf00431693 |
0.399 |
|
| 1981 |
de la Garza R, Bergman J, Hartel CR. Food deprivation and cocaine self-administration. Pharmacology, Biochemistry, and Behavior. 15: 141-4. PMID 7291222 DOI: 10.1016/0091-3057(81)90353-1 |
0.354 |
|
| 1981 |
Bergman J, Johanson CE. The effects of electric shock on responding maintained by cocaine in rhesus monkeys. Pharmacology, Biochemistry, and Behavior. 14: 423-6. PMID 7232468 DOI: 10.1016/0091-3057(81)90413-5 |
0.348 |
|
| Show low-probability matches. |